WeVote
Log In

Bill

Bill

SB 392

Maryland Technology Development Corporation - Long COVID Innovation Grant and Loan Program

2026 Regular Session Introduced by Nancy King

Maryland creates Long COVID innovation grant and loan program to fund treatment and diagnostic research through state technology development corporation.

Hearing 2/12 at 1:00 p.m.
0
WeVote Research Nonpartisan
Bill Summary · SB 392

Legislative bill overview

SB 392 establishes a Long COVID Innovation Grant and Loan Program through Maryland's Technology Development Corporation to fund research, development, and commercialization of treatments and diagnostics for Long COVID. The bill allocates state resources to support businesses and researchers working on Long COVID solutions, creating both grant funding and low-interest loan opportunities for eligible applicants.

Why is this important

Long COVID affects hundreds of thousands of Americans with persistent symptoms months or years after initial infection, yet treatment options remain limited. By creating dedicated funding mechanisms, Maryland would position itself as a leader in Long COVID innovation while potentially accelerating development of therapies that could benefit patients nationally. This addresses a significant public health gap where private market incentives alone have not sufficiently funded solutions.

Potential points of contention

  • Fiscal impact and state budget constraints: The bill requires state funding during economic uncertainty, raising questions about budget priorities and whether this represents the best use of limited resources compared to other health or innovation initiatives
  • Market viability concerns: Critics may question whether state grants/loans are necessary if Long COVID treatments have genuine commercial potential, or whether this subsidizes ventures that should attract private investment
  • Scope and definition challenges: Determining what qualifies as Long COVID-related innovation and preventing mission creep or duplicative funding with existing research programs could prove administratively complex

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.